Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Future Medicinal Chemistry

• Publication date

  2012-03-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4155/fmc.12.1PMID 22393940PMCID PMC3320517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyanoquinolines with Independent Corrector and Potentiator Activities Restore ΔPhe508-Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Function in Cystic Fibrosis

  2011cited by this paper
• Targeting the regulation of CFTR channels.

  2011cited by this paper
• Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

  2011cited by this paper
• Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations*

  2011cited by this paper
• Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.

  2011cited by this paper
• Bioactive phospholipid signaling influences NHE3-dependent intestinal Na(+) and fluid absorption: a macromolecular complex perspective. Focus on "Lysophosphatidic acid 5 receptor induces activation of Na(+)/H(+) exchanger 3 via apical epidermal growth factor receptor in intestinal epithelial cells".

  2011cited by this paper
• Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809

  2011cited by this paper
• Developing novel antisecretory drugs to treat infectious diarrhea.

  2011cited by this paper
• A Tannic Acid-Based Medical Food, Cesinex®, Exhibits Broad-Spectrum Antidiarrheal Properties: A Mechanistic and Clinical Study

  2011cited by this paper
• Functional regulation of cystic fibrosis transmembrane conductance regulator-containing macromolecular complexes: a small-molecule inhibitor approach.

  2011cited by this paper
• Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis

  2010cited by this paper
• Small Molecule AKAP-Protein Kinase A (PKA) Interaction Disruptors That Activate PKA Interfere with Compartmentalized cAMP Signaling in Cardiac Myocytes

  2010cited by this paper
• Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.

  2010cited by this paper
• A Plant-Derived Hydrolysable Tannin Inhibits CFTR Chloride Channel: A Potential Treatment of Diarrhea

  2010cited by this paper
• Crofelemer, an Antisecretory Antidiarrheal Proanthocyanidin Oligomer Extracted from Croton lechleri, Targets Two Distinct Intestinal Chloride Channels

  2010cited by this paper
• Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening

  2010cited by this paper
• CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners.

  2010cited by this paper
• Crofelemer, a Novel Agent for Treatment of Secretory Diarrhea

  2010cited by this paper
• Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2.

  2010cited by this paper
• CFTR Modulators for the Treatment of Cystic Fibrosis

  2010cited by this paper
• Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR.

  2010cited by this paper
• Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

  2009cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Biological and chemical approaches to diseases of proteostasis deficiency.

  2009cited by this paper
• Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.

  2009cited by this paper
• Clinical and molecular characterization of S1118F‐CFTR

  2009cited by this paper
• Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD

  2009cited by this paper
• Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.

  2009cited by this paper
• A Small-Molecule Modulator Interacts Directly with ΔPhe508-CFTR to Modify Its ATPase Activity and Conformational Stability

  2009cited by this paper
• Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice.

  2009cited by this paper
• Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function

  2008cited by this paper
• Enhanced cell-surface stability of rescued DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones.

  2008cited by this paper
• Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides.

  2008cited by this paper
• Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

  2008cited by this paper
• A Natural Plant-Derived Dihydroisosteviol Prevents Cholera Toxin-Induced Intestinal Fluid Secretion

  2008cited by this paper
• Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia.

  2007cited by this paper
• Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions.

  2007cited by this paper
• Design of a selective chemical probe for class I PDZ domains.

  2007cited by this paper
• Building an understanding of cystic fibrosis on the foundation of ABC transporter structures

  2007cited by this paper
• An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth.

  2007cited by this paper
• Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera.

  2007cited by this paper
• Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.

  2006cited by this paper
• Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid loss in cholera

  2006cited by this paper
• CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.

  2006cited by this paper
• Phosphodiesterases and compartmentalized cAMP signalling in the heart.

  2006cited by this paper
• Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening.

  2005cited by this paper
• Cocoa-related flavonoids inhibit CFTR-mediated chloride transport across T84 human colon epithelia.

  2005cited by this paper
• Designed multiple ligands. An emerging drug discovery paradigm.

  2005cited by this paper
• Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions

  2005cited by this paper
• In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents.

  2005cited by this paper
• Structure of nucleotide‐binding domain 1 of the cystic fibrosis transmembrane conductance regulator

  2004cited by this paper
• Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor.

  2004cited by this paper
• Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors

  2004cited by this paper
• A selective irreversible inhibitor targeting a PDZ protein interaction domain.

  2003cited by this paper
• Discrete Microdomains with High Concentration of cAMP in Stimulated Rat Neonatal Cardiac Myocytes

  2002cited by this paper
• A macromolecular complex of β2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA

  2002cited by this paper
• Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

  2002cited by this paper
• Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening

  2002cited by this paper
• A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion.

  1999cited by this paper
• Tannins and human health: a review.

  1998cited by this paper
• Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

  1994cited by this paper
• Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

  1993cited by this paper
• The cystic fibrosis transmembrane conductance regulator.

  1993cited by this paper
• Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).

  1992cited by this paper
• Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.

  1991cited by this paper
• Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

  1990cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper

• Dietary lysophospholipid alleviates diarrhea and improves intestinal health in weaned piglets challenged with enterotoxigenic Escherichia coli K88.

  2025cites this paper
• An Asset for Food Safety: The Knowledge Behind the Physiological Alterations Induced by ETEC Enterotoxins

  2025cites this paper
• Beyond the mutations: spatiotemporal regulation of CFTR by cAMP and calcium signaling in epithelial physiology and cystic fibrosis

  2025cites this paper
• Multitarget Actions of TongXie-Ning Granules Against the Gut Dysfunctions of Diarrhea-Predominant Irritable Bowel Syndrome.

  2025cites this paper
• T‐bet Regulates Ion Channels and Transporters and Induces Apoptosis in Intestinal Epithelial Cells

  2024cites this paper
• Fractional Exhalation Nitric Oxide (FeNO) changes in cystic fibrosis patients induced by compound honey syrup: a pretest–posttest clinical trial

  2023cites this paper
• Clinical course and therapeutic trial for a case of congenital secretory diarrhea due to novel GUCY2C variant

  2023cites this paper
• Tannins extract from Galla Chinensis can protect mice from infection by Enterotoxigenic Escherichia coli O101

  2021cites this paper
• Proteasome-dependent protein quality control of the peroxisomal membrane protein Pxa1p.

  2020cites this paper
• Investigation the Lifestyle in Patients with Cystic Fibrosis According to Iranian Traditional Medicine

  2020cites this paper
• Fibrocyte accumulation in the lungs of cystic fibrosis patients.

  2020cites this paper
• Microarray analysis reveals the inhibition of intestinal expression of nutrient transporters in piglets infected with porcine epidemic diarrhea virus

  2019cites this paper
• Discovery of a novel chalcone derivative inhibiting CFTR chloride channel via AMPK activation and its anti-diarrheal application.

  2019cites this paper
• Efficacy of antidiarrheal Thai medicinal plants in chloride channel inhibition

  2018cites this paper
• Prevention and treatment of secretory diarrhea by the lysophosphatidic acid analog Rx100

  2018cites this paper
• Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.

  2018cites this paper
• CFTR-NHERF2-LPA2 Complex in the Airway and Gut Epithelia

  2017cites this paper
• Differential expression of intestinal ion transporters and water channel aquaporins in young piglets challenged with enterotoxigenic Escherichia coli K88.

  2017cites this paper
• Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice

  2017cites this paper
• Structural Basis Of Membrane Protein Scaffolding And Signaling In Human Disease

  2017cites this paper
• Beyond cystic fibrosis transmembrane conductance regulator (CFTR) single channel kinetics: implications for therapeutic intervention

  2017cites this paper
• Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis

  2016cites this paper
• Correctors of mutant CFTR enhance subcortical cAMP–PKA signaling through modulating ezrin phosphorylation and cytoskeleton organization

  2016cites this paper
• PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.

  2015cites this paper
• Oridonin: a small molecule inhibitor of cystic fibrosis transmembrane conductance regulator (CFTR) isolated from traditional Chinese medicine.

  2015cites this paper
• Drug-induced secretory diarrhea: A role for CFTR.

  2015cites this paper
• Identification of Chemical Correctors for the Trafficking Defect of Mutant SLC4A11

  2015cites this paper
• Modulation of Chloride Channel Functions by the Plant Lignan Compounds Kobusin and Eudesmin

  2015influential citation
• Thiéno [2,3-c] pyrannes utilisés en tant que modulateurs du cftr

  2014cites this paper
• Corneal Dystrophy‐Causing SLC4A11 Mutants: Suitability for Folding‐Correction Therapy

  2014cites this paper
• Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator.

  2014cites this paper
• Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.

  2014cites this paper
• Structural insights into PDZ-mediated interaction of NHERF2 and LPA(2), a cellular event implicated in CFTR channel regulation.

  2014cites this paper
• Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS

  2013cites this paper
• Regulation of CFTR Endocytosis by the Vasoactive Intestinal Peptide: Role of PKCε

  2013influential citation
• Microfluidics platform for single-shot dose-response analysis of chloride channel-modulating compounds.

  2013cites this paper
• Convective washout reduces the antidiarrheal efficacy of enterocyte surface–targeted antisecretory drugs

  2013cites this paper
• Design of folic acid, transferrin, and integrin receptor specific polyamidoamine dendrimers for gene delivery

  2012cites this paper
• Bioactive phospholipid signaling influences NHE3-dependent intestinal Na(+) and fluid absorption: a macromolecular complex perspective. Focus on "Lysophosphatidic acid 5 receptor induces activation of Na(+)/H(+) exchanger 3 via apical epidermal growth factor receptor in intestinal epithelial cells".

  2011cites this paper